Elly Mesman
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Drug Transport and Resistance Mechanisms
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
- Oncology 7
- Drug Transport and Resistance Mechanisms 2
- Cancer Immunotherapy and Biomarkers 2
- CAR-T cell therapy research 2
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 2
- Co-authors
- Alexander Griekspoor (2 shared papers)Jeffrey Schlom (2 shared papers)Tom A. Groothuis (2 shared papers)Carla Herberts (2 shared papers)Elizabeth K. Wansley (2 shared papers)Frank A. W. Verreck (2 shared papers)Joost Neijssen (2 shared papers)Mala Chakraborty (2 shared papers)
- Journals
- Drug Metabolism and Disposition (1 paper)Nature Medicine (1 paper)The Journal of Immunology (1 paper)Clinical Cancer Research (1 paper)Blood (1 paper)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Elly Mesman
9 papers receiving 2.8k citations
Elly Mesman's Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.6k
- Cancer Research 642
- Immunology 877
- Molecular Biology 874
- Pulmonary and Respiratory Medicine 287
Countries citing papers authored by Elly Mesman
This map shows the geographic impact of Elly Mesman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elly Mesman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elly Mesman more than expected).
Fields of papers citing papers by Elly Mesman
This network shows the impact of papers produced by Elly Mesman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elly Mesman. The network helps show where Elly Mesman may publish in the future.
Co-authors
The 25 scholars most cited alongside Elly Mesman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy Hit paper breakdown → | 2006 | 1397 |
| 2 | Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation Hit paper breakdown → | 2007 | 695 |
| 3 | 2005 | 339 | |
| 4 | 2011 | 106 | |
| 5 | 2008 | 103 | |
| 6 | 2006 | 68 | |
| 7 | 2006 | 57 | |
| 8 | 2006 | 50 | |
| 9 | 2008 | 36 |
About Elly Mesman
Elly Mesman is a scholar working on Oncology, Immunology, Molecular Biology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 9 papers that have together received 2.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacological Effects and Toxicity Studies (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers), CAR-T cell therapy research (2 papers), Epigenetics and DNA Methylation (1 paper) and Acute Lymphoblastic Leukemia research (1 paper). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (642 citations), Immunology (877 citations), Molecular Biology (874 citations) and Pulmonary and Respiratory Medicine (287 citations). Elly Mesman has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Alexander Griekspoor, Jeffrey Schlom, Tom A. Groothuis, Carla Herberts, Elizabeth K. Wansley, Frank A. W. Verreck, Joost Neijssen, Mala Chakraborty, Peter A. van Veelen and James W. Hodge. Their work appears in journals such as Drug Metabolism and Disposition, Nature Medicine, The Journal of Immunology, Clinical Cancer Research and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.